• Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension

  NCT00461903

  CompletedInterventionalPhase 3Updated Feb 21, 2020
• Perindopril Amlodipine for the Treatment of Hypertension

  NCT01556997

  CompletedInterventionalPhase 3Updated Sep 28, 2015
• Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

  NCT05820880

  CompletedInterventionalPhase 3Updated Jul 25, 2024
• Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril

  NCT03730116

  CompletedObservationalUpdated Jan 13, 2021
• PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril

  NCT04656847

  CompletedObservationalUpdated Nov 1, 2024
• Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

  NCT02655029

  CompletedObservationalUpdated Mar 24, 2017

ClinicalTrials.gov ID

NCT04484688

Lead Sponsor

Aversi ClinicOTHER

Overall Status

Unknown status

Study Type

Observational

Enrollment

50Estimated

Last Update Posted

Jul 23, 2020Actual

Start Date

Aug 1, 2020Estimated

Primary Completion Date

Sep 1, 2021Estimated

Completion Date

Dec 1, 2021Estimated

Official Title

Perindopril+Bisoprolol in Therapy of Patients With Atrial Fibrilation

Brief Summary

The study aims to evaluate the effectiveness and safety of oral fixed-dose combination of bisoprolol/perindopril in patients with permanent atrial fibrillation

• Patient Participation

• perindopril-bisoprolol

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:permanent atrial fibrillation with normal EF -

Exclusion Criteria:AF with decreased EF

-

Observational Model

Case-Only

Time Perspective

Prospective

Lead Sponsor

Aversi ClinicOTHER

dvmaisuradze@hotmail.com0995599950556